Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Survival Analysing of the Breast Cancer Patients Using Cure Model Publisher



Bakhshi E1 ; Sheikhaliyan A2 ; Atashgar K2 ; Kooshesh M3 ; Biglarian A4
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Biostatistics, University of Social Welfare and Rehabilitation Sciences, Tehran, Iran
  2. 2. Department of Industrial Engineering, Malek Ashtar University of Technology, Tehran, Iran
  3. 3. Tehran University of Medical Sciences, Tehran, Iran
  4. 4. Department of Biostatistics, Pediatric Neurorehabilitation Research Center, University of Social Welfare and Rehabilitation Sciences, Tehran, Iran

Source: Iranian Red Crescent Medical Journal Published:2017


Abstract

Background: Breast cancer (BC) is the most leading cause of cancer and the second most common cause of cancer-related death among females worldwide. The survival time of the disease and its risk factors are important for physicians. Objectives: The current study aimed at applying the Cox, cure, and frailty models to identify the risk factors related to the survival of patients with BC. Methods: The current historical cohort study investigated 499 patients with a confirmed diagnosis of BC, from March 2010 to March 2014, and followed-up to March 2015 in Besaat hospital in Tehran, Iran. The Cox regression, cure, and frailty models were used for the survival analysis (SA) of the patients. Data analysis was carried out by R3.2.2 software. Results: The mean (± SD) age of the patients was 50.39 (± 11.13) years and the mean survival time was 53.44 months (95% CI: 51.41 - 55.48). In addition, the 1-year overall survival ratewas0.92 (95% CI: 0.89 - 0.94). Age at diagnosis, tumor size, and metastasis covariates were significant in all models (P < 0.05). Stage covariate were significant in frailty, cure, and failure time distribution model (P < 0.001). Familial history (P = 0.016) and pathology (P = 0.012) were significant only in the frailty model. Conclusions: The cure and frailty models were better than the Cox model to estimate the parameters. When some patients have a long-term survival, cure models can be an interesting method to study survival and also describe the short-term and long-term effects. © 2017, Iranian Red Crescent Medical Journal.
Related Docs
1. Survival Rates of Patients With Breast Cancer in Countries in the Eastern Mediterranean Region: A Systematic Review and Meta-Analysis; [Taux De Survie Des Patients Atteints De Cancer Du Sein Dans Les Pays De La Region De La Mediterranee Orientale: Analyse Systematique Et Meta-Analyse], Eastern Mediterranean Health Journal (2020)
2. The Global and Regional Survival Rate of Women With Breast Cancer: A Systematic Review and Meta-Analysis, Clinical Breast Cancer (2019)
3. Treatment Outcomes and Clinicopathologic Characteristics of Triple-Negative Breast Cancer: A Report From Cancer Institute of Iran, International Journal of Hematology-Oncology and Stem Cell Research (2017)
4. A Comprehensive Reference for Brca1/2 Genes Pathogenic Variants in Iran: Published, Unpublished and Novel, Familial Cancer (2022)
5. Investigation of Prognostic Factors of Survival in Breast Cancer Using a Frailty Model: A Multicenter Study, Breast Cancer: Basic and Clinical Research (2019)
Experts (# of related papers)
View all Related Experts
Hojjat Zeraati (1)
Farhad Shahi (1)